Back to top
more

Myriad Genetics: (MYGN)

(Delayed Data from NSDQ)

 Add to portfolio

$36.00 USD

36.00
601,186

-1.15 (-3.10%)

Updated Apr 29, 2016 03:59 PM ET

Volume: 601,186

Open: $36.89

Prior Close: $37.15

The Zacks Scorecard is a complimentary set of indicators to use alongside the Zacks Rank. It allows the investor to better focus on the stocks that are the best fit for his or her personal investment style.

We produce five unique ratings, including the Zacks Style Score, which combines the individual style scores into 1 rating:

Zacks Style Score A
Growth Score A
Value Score A
Momentum Score A
Income Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a score of an A or a B in your personal trading style.

Zacks Scorecard Education - Learn more about the Zacks Scorecard

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 25.71%
2 Buy 18.12%
3 Hold 9.91%
4 Sell 5.49%
5 Strong Sell 2.29%
S&P 500 9.79%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

Myriad Genetics (MYGN) Quote Overview » Financials » Myriad Genetics (MYGN) Balance Sheet

Balance Sheet

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

Trades from $3

Fiscal Year End for MYRIAD GENETICS falls in the month of June.

All items in Millions except Per Share data.

6/30/2015 6/30/2014 6/30/2013 6/30/2012 6/30/2011
Assets          
Cash & Equivalents 145 186 372 341 346
Receivables 88 85 98 63 51
Notes Receivable 0 0 0 0 0
Inventories 25 24 5 12 6
Other Current Assets 26 27 9 7 15
Total Current Assets 284 322 484 422 418
Net Property & Equipment 67 35 28 24 23
Investments & Advances 41 84 159 114 71
Other Non-Current Assets 0 0 22 19 0
Deferred Charges 0 3 29 31 26
Intangibles 370 374 70 73 73
Deposits & Other Assets 5 5 13 8 0
Total Assets 766 824 804 691 611
Liabilities & Shareholders Equity 6/30/2015 6/30/2014 6/30/2013 6/30/2012 6/30/2011
Notes Payable 0 0 0 0 0
Accounts Payable 21 23 18 10 11
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 46 56 44 33 22
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 2 1 2 2 1
Total Current Liabilities 69 81 65 45 34
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 0 0 0 0 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 35 24 11 10 10
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 104 105 75 55 44
Shareholders Equity 6/30/2015 6/30/2014 6/30/2013 6/30/2012 6/30/2011
Preferred Stock 0 0 0 0 0
Common Stock (Par) 1 1 1 1 1
Capital Surplus 745 718 697 648 604
Retained Earnings -77 2 31 -13 -39
Other Equity -7 -2 -0 -0 0
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 662 719 729 636 567
Total Liabilities & Shareholder's Equity 766 824 804 691 611
Total Common Equity 662 719 729 636 567
Shares Outstanding 69.40 74.80 79.60 84.80 85.70
Book Value Per Share 9.54 9.61 9.15 7.50 6.61

Fiscal Year End for MYRIAD GENETICS falls in the month of June.

All items in Millions except Per Share data.

3/31/2016 12/31/2015 9/30/2015 6/30/2015 3/31/2015
Assets          
Cash & Equivalents NA 219 155 145 134
Receivables NA 89 85 88 95
Notes Receivable NA 0 0 0 0
Inventories NA 29 34 25 29
Other Current Assets NA 38 33 26 23
Total Current Assets NA 376 307 284 282
Net Property & Equipment NA 62 65 67 69
Investments & Advances NA 66 43 41 41
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 363 367 370 381
Deposits & Other Assets NA 5 5 5 5
Total Assets NA 872 787 766 779
Liabilities & Shareholders Equity 3/31/2016 12/31/2015 9/30/2015 6/30/2015 3/31/2015
Notes Payable NA 0 0 0 0
Accounts Payable NA 17 16 21 18
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 48 42 46 48
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 2 1 2 1
Total Current Liabilities NA 66 59 69 67
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 7 0 10
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 0 0 0 0
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 34 35 33
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 101 100 104 110
Shareholders Equity 3/31/2016 12/31/2015 9/30/2015 6/30/2015 3/31/2015
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 1 1 1 1
Capital Surplus NA 848 772 745 738
Retained Earnings NA -69 -79 -77 -62
Other Equity NA -9 -7 -7 -8
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 771 687 662 669
Total Liabilities & Shareholder's Equity NA 872 787 766 779
Total Common Equity 0 771 687 662 669
Shares Outstanding 71.20 69.70 69.30 69.40 71.10
Book Value Per Share 0.00 11.06 9.91 9.54 9.41